Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protective effect of interferon on the liver solved – targeted treatment approaches available, soon?

06.11.2013
Type I interferons are used for treatment of viral hepatitis because of their antiviral and thus, hepatoprotective effects. Treatment with interferon, however, involves severe adverse effects.

Researchers at the Paul-Ehrlich-Institut have now found the mechanism of how interferon protects the liver. In this context, specific suppressor cells and the balance between the inflammation mediator interleukin-1beta and its inhibitor, the interleukin-1 receptor antagonist play a central role. The findings may provide approaches to a more specific therapy with fewer adverse effects.


Liver histology of mice after treatment with poly(I:C). Control mice (WT) are protected by an interferon-mediated effect, mice without the interferon receptor (IFNAR-/-) develop severe liver damage.

Source: Paul-Ehrlich-Institut

Hepatology reports on the research results in its online prepublication (DOI:10.1002/hep.26915).

Type I interferons are mainly associated with their immunostimulatory, antiviral, and antitumoral effects. However, they also have anti-inflammatory properties. Thus, in patients with a liver inflammation due to a chronic hepatitis-C virus infection, interferon may improve the condition of the liver. This can also be observed when, thanks to treatment, the viral burden is negligible already.

PD (associate professor) Dr Zoe Waibler, head of a temporary research group at the Paul-Ehrlich-Institut (PEI), and co-workers have studied the mechanism which results in this protective effect. For the study not a virus but poly(I:C), an artificial double-stranded RNA which mimics a viral infection, was used. Poly(I:C) was applied to interferon receptor-deficient (IFNAR-deficient) mice and genetically unmodified control mice.

In IFNAR-deficient mice, the treatment with poly(I:C) induced a severe acute liver damage with necrosis, while the control animals were protected. Similarly to human liver inflammations, serum levels of the enzyme alanine aminotransferase also increased upon poly(I:C) treatment of IFNAR-deficient mice, while those of the control mice did not.

In collaboration with Professor Christian Bogdan, Institute of Clinical Microbiology, Immunology, and Hygiene of the University Hospital of Erlangen, the team of PEI researchers identified certain suppressor cells ("myeloid derived suppressor cells", MDSC) as mediators of protection: Upon type I interferon expression, these cells infiltrate the liver, where they convey the protective effect. The team achieved this by switching off the interferon receptor on individual cell types and studying specific surface markers.

Dr Waibler and co-workers were able to show that these suppressor cells influence the balance between the pro- inflammatory cytokine interleukin-1beta (IL-1beta) and its naturally occurring inhibitor, anti-inflammatory interleukin-1 receptor antagonist (IL-1RA) in the liver: For IFNAR-deficient mice, there was a drastic shift toward inflammatory IL-1beta upon poly(I:C) treatment, while for the control mice, the shift occurred in the direction of the anti-inflammatory IL-1RA.

The fact that IL-1beta and IL-1RA indeed induced the inflammatory or protective effects, respectively, in the liver could be proved by Dr Waibler and co-workers by administrating IL-1RA to IFNAR-deficient mice, which prevented the liver damage induced by poly(I:C). Although interferon could not mediate the protective effect here, due to the missing interferon receptor, the downstream effects, normally mediated by interferon, was restored by the administration of IL-1RA. Likewise, liver functions improved in IFNAR-deficient mice if the inflammatory cytokine IL-1beta was neutralized by adding an anti-IL-1beta antibody.

"Interferons have extremely versatile effects by regulating up to 300 genes, thus bringing about a great variety of effects. Only a minor part of them is responsible for this effect on the liver. Maybe an organ-specific therapy would be possible here", explained Dr Waibler with regard to a potential clinical use of these results. Biotechnologically engineered IL-1RA is used in the treatment of rheumatoid arthritis. In addition, there is a genetically engineered monoclonal antibody directed against IL-1beta, which is used in patients with a particular genetic defect.

The PEI researchers also have an explanation for the fact that the suppressor cells in the control mice infiltrate the liver: Based on experimental results, they assume that interferons switch on a particular chemokine in the liver, which attracts the suppressor cells (MDSC).

"Many immunological processes are not fully understood, yet. With our fundamental research, we contribute to developing approaches to therapies that are effective but at the same time cause as few adverse effects as possible", emphasised Professor Cichutek, president of the Paul-Ehrlich-Institut.

Original publication

DOI:10.1002/hep.26915; unedited version

Conrad E, Resch TK, Gogesch P, Kalinke U, Bechmann I, Bogdan C, Waibler Z (2013): Protection against RNA-induced liver damage by myeloid cells requires type I IFN and IL-1 receptor antagonist. Hepatology [Epub ahead of print].

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and veterinary vaccines. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.

Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the varied and many tasks performed at the institute.

The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).

Weitere Informationen:

http://onlinelibrary.wiley.com/doi/10.1002/hep.26915/abstract
Abstract of the publication (accepted, unedited)
http://www.pei.de/EN/information/journalists-press/press-releases/2013/12-protective-effect-interferon-liver-solved.html

Press Release on the Paul-Ehrlich-Institut Website

Dr. Susanne Stöcker | idw
Further information:
http://www.pei.de

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>